High dose chemotherapy and autologous bone marrow transplantation in refractory Hodgkin's disease.

High dose chemotherapy and autologous bone marrow transplantation in refractory Hodgkin's disease.

Seventeen patients with Hodgkin's disease (HD) were treated with high-dose chemotherapy followed by autologous bone marrow transplantation (ABMT). Eleven patients were resistant to initial therapy. Three patients had relapsed and were still responders to second or third line therapy. Three pati...

Full description

Bibliographic Details
Main Authors: Philip, T., Dumont, J., Teillet, F., Maraninchi, D., Gorin, N. C., Kuentz, M., Harousseau, J. L., Marty, M., Pinkerton, R., Herve, P.
Format: Online
Language:English
Published: 1986
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2001409/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2001409/

Similar Items